Production and characterisation of monoclonal antibodies for the detection of AOZ, a tissue bound metabolite of furazolidone

M. Vass, L. Kotkova, I. Diblikova, Z. Nevorankova, K.M. Cooper, D.G. Kennedy and M. Franek
Additional contact information
M. Vass: Veterinary Research Institute, Brno, Czech Republic
L. Kotkova: Veterinary Research Institute, Brno, Czech Republic
I. Diblikova: Veterinary Research Institute, Brno, Czech Republic
Z. Nevorankova: Veterinary Research Institute, Brno, Czech Republic
K.M. Cooper: Queen's University Belfast, Department of Veterinary Science, Northern Ireland, UK
D.G. Kennedy: Chemical Surveillance Branch, Veterinary Sciences Division, Department of Agriculture & Rural Development, Belfast, Northern Ireland, UK
M. Franek: Veterinary Research Institute, Brno, Czech Republic

Veterinární medicína, 2005, vol. 50, issue 7, 300-310

Abstract: 3-amino-2-oxazolidinone (AOZ) is a tissue bound toxic metabolite derived from the nitrofuran antibiotic, furazolidone. AOZ is detected in the derivatised form of 3-{[(2-nitrophenyl) methylene] amino}-2-oxa-zolidinone (NP AOZ). 3-{[(3-carboxyphenyl)-methylene] amino-2-oxazolidinone (CP AOZ) was used as the immunising hapten for the production of monoclonal antibodies against NP AOZ. Monoclonal antibodies were produced using hybridomas from the fusion of murine myeloma cells and spleen cells isolated from BALB/c mice immunised with CP AOZ-ethylenediamine-human serum albumin (CP AOZ-ed-HSA). The antibody production in ascitic fluids from clones 3B8/2B9 and 2D11/A4 was monitored during a 16 month period. Repeated cultures of these hybridomas, followed by injection into mice and cloning did not change the assay parameters. Clone 2D11/A4 exhibited long term stability in antibody production throughout the experiment whereas clone 3B8/2B9 demonstrated variability in particular antibody yields whilst retaining assay sensitivity. Reasons for this production variability in clones are discussed. In an optimised direct ELISA format, the antibodies exhibited a 50% binding inhibition in the range of 0.52-1.15 ng/ml with NP AOZ (0.22 -0.50 ng/ml, respective AOZ equivalents) and showed high specificity towards this analyte. The sensitivity of monoclonal antibodies incorporated into the ELISA is compatible with the European Union MRLP and is currently in use for routine analysis.

Keywords: furazolidone; AOZ; hybridomas; monoclonal antibodies; ELISA; immunochemical characterisation; production stability (search for similar items in EconPapers)
Date: 2005
References: View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://vetmed.agriculturejournals.cz/doi/10.17221/5627-VETMED.html (text/html)
http://vetmed.agriculturejournals.cz/doi/10.17221/5627-VETMED.pdf (application/pdf)
free of charge

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:caa:jnlvet:v:50:y:2005:i:7:id:5627-vetmed

DOI: 10.17221/5627-VETMED

Access Statistics for this article

Veterinární medicína is currently edited by Ing. Helena Smolová Ph.D.

More articles in Veterinární medicína from Czech Academy of Agricultural Sciences
Bibliographic data for series maintained by Ivo Andrle ().